American Well (AMWL) DHA contract a 'clear positive' - Wells Fargo

Wells Fargo analyst Stephen Baxter reiterated an Equal Weight rating and $2.00 price target on American Well Corp. (NYSE: AMWL), calling the DHA contract a "clear positive."

The analyst commented, "While specific economics for Amwell are not clear, we view this contract as a clear positive development for the company and a vote of confidence in the capability of its Converge platform. We expect to get more details alongside 3Q earnings on 11/1."

For an analyst ratings summary and ratings history on American Well Corp. click here. For more ratings news on American Well Corp. click here.

Shares of American Well Corp. closed at $1.02 yesterday.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer